About Hunan Jingfeng Pharmaceutical Company

The company was listed in December 2014. Adhering to the concept of “consolidating the foundation, technological innovation, and sustainable development”, the company adheres to the path of industrialization of high-end specialty generic drugs in line with the international community. The company's main business products cover major diseases such as cardiovascular, oncology, orthopedics, pediatrics, gynecology, etc. The company is an enterprise focusing on the medical and health industry. It is involved in pharmaceutical R&D, production, sales and other businesses, as well as in the field of pharmaceutical investment. The company's products include: Shenxiao Glucose Injection, Tirofiban Hydrochloride Concentrated Solution, Tirofiban Hydrochloride Sodium Chloride Injection, Diltiazem Hydrochloride and Lemak Pills for Injection, Pemetrexed Disodium for Injection, Gemcitabine Hydrochloride, Irinotecan Hydrochloride Injection, Fludarabine Hydrochloride for Injection, Oxaliplatin and Letrozole Tablets, Funin Capsules (Exclusive Nationwide), Pantoprazole Sodium for Injection, Omeprazole Sodium for Injection, Solanazole for Injection Ice Gardenia Pain Aerosol (Nationwide Exclusive), Clindamycin Hydrochloride Phosphate for Injection, Adenosine Monophosphate for Injection, Injection Ganciclovir, compound lyuzole aerosol (national exclusive), voriconazole tablets, medical sodium hyaluronate gel, flubiprofen ester injections, etc.